AIP
CSTL icon

Ameritas Investment Partners’s Castle Biosciences CSTL Stock Holding History

Ameritas Investment Partners’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.8K Buy
2,717
+344
+14% +$7.66K ﹤0.01% 2096
2026
Q1 		$58.3K Hold
2,373
– – ﹤0.01% 2012
2025
Q4 		$92.3K Hold
2,373
– – ﹤0.01% 1758
2025
Q3 		$54K Sell
2,373
-527
-18% -$10.7K ﹤0.01% 2066
2025
Q2 		$59.2K Buy
2,900
+450
+18% +$8.33K ﹤0.01% 2078
2025
Q1 		$49K Hold
2,450
– – ﹤0.01% 2109
2024
Q4 		$65.3K Hold
2,450
– – ﹤0.01% 2026
2024
Q3 		$69.9K Hold
2,450
– – ﹤0.01% 1997
2024
Q2 		$53.3K Hold
2,450
– – ﹤0.01% 2110
2024
Q1 		$54.3K Hold
2,450
– – ﹤0.01% 2102
2023
Q4 		$52.9K Hold
2,450
– – ﹤0.01% 2138
2023
Q3 		$41.4K Buy
2,450
+779
+47% +$13.6K ﹤0.01% 2206
2023
Q2 		$22.9K Hold
1,671
– – ﹤0.01% 2496
2023
Q1 		$38K Hold
1,671
– – ﹤0.01% 2145
2022
Q4 		$45.1K Hold
1,671
– – ﹤0.01% 2130
2022
Q3 		$43K Hold
1,671
– – ﹤0.01% 2088
2022
Q2 		$36K Hold
1,671
– – ﹤0.01% 2202
2022
Q1 		$75K Hold
1,671
– – ﹤0.01% 1811
2021
Q4 		$72K Hold
1,671
– – ﹤0.01% 1893
2021
Q3 		$111K Hold
1,671
– – ﹤0.01% 1616
2021
Q2 		$123K Buy
1,671
+486
+41% +$32.1K ﹤0.01% 1594
2021
Q1 		$81K Buy
1,185
+186
+19% +$14K ﹤0.01% 1783
2020
Q4 		$67K Hold
999
– – ﹤0.01% 1805
2020
Q3 		$51K Buy
999
+175
+21% +$7.79K ﹤0.01% 1820
2020
Q2 		$31K Hold
824
– – ﹤0.01% 2105
2020
Q1 		$25K Buy
824
+514
+166% +$15.5K ﹤0.01% 2047
2019
Q4 		$11K Hold
310
– – ﹤0.01% 2686
2019
Q3 		$6K Buy
+310
New +$6.87K ﹤0.01% 2884

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameritas Investment Partners's CSTL Position: Q2 2026 in Review

Ameritas Investment Partners increased its Castle Biosciences (CSTL) stake by 14% in Q2 2026, buying an estimated $7.66K and bringing the position to 2,717 shares worth $64.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2096.

Ameritas Investment Partners first reported a position in CSTL in Q3 2019 and has held it in 28 quarters since. The position peaked at $123K in Q2 2021. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Ameritas Investment Partners held 2,717 shares of Castle Biosciences worth $64.8K as of Q2 2026.
  • Ameritas Investment Partners bought 344 Castle Biosciences shares in Q2 2026, an estimated $7.66K.
  • Castle Biosciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2096 holding.
  • Ameritas Investment Partners first reported a position in Castle Biosciences in Q3 2019 and has held it in 28 quarters since.
  • Ameritas Investment Partners's Castle Biosciences position peaked at $123K in Q2 2021.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.